Skip Content
You are currently on the new version of our website. Access the old version .
AntioxidantsAntioxidants
  • Review
  • Open Access

18 April 2023

Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products

and
1
Department of Biochemistry and Central Research Laboratory, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar University (Deemed to be), Mullana, Ambala 133207, India
2
Department of Biology, University of Padova, Via Ugo Bassi 58/B, 35131 Padova, Italy
3
Study Center for Neurodegeneration (CESNE), 35121 Padova, Italy
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Oxidative Stress and Inflammation in Movement Disorders

Abstract

Parkinson’s disease (PD) is a chronic neurodegenerative condition affecting more than 1% of people over 65 years old. It is characterized by the preferential degeneration of nigrostriatal dopaminergic neurons, which is responsible for the motor symptoms of PD patients. The pathogenesis of this multifactorial disorder is still elusive, hampering the discovery of therapeutic strategies able to suppress the disease’s progression. While redox alterations, mitochondrial dysfunctions, and neuroinflammation are clearly involved in PD pathology, how these processes lead to the preferential degeneration of dopaminergic neurons is still an unanswered question. In this context, the presence of dopamine itself within this neuronal population could represent a crucial determinant. In the present review, an attempt is made to link the aforementioned pathways to the oxidation chemistry of dopamine, leading to the formation of free radical species, reactive quinones and toxic metabolites, and sustaining a pathological vicious cycle.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.